Skip to main content

Catalio Capital Management — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

139
Companies
$11.4B
Total invested
$82.0M
Avg. check
29
Industries
Health Care 15Biotechnology 14Therapeutics 10Artificial Intelligence (AI) 9Pharmaceutical 8Life Science 7+23 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 139
Somethings
October 2026

Somethings provides a digital peer mentorship platform that connects teenagers and young adults for social and emotional support.

Health Care · New York$2.6M Grant
XRHealth
October 2026

XRHealth is a telemedicine company that uses virtual reality and augmented reality solutions for healthcare applications.

Augmented Reality · Needham Heights$2.1M Venture - Series Unknown
Star Therapeutics
October 2026

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health Care · South San Francisco$200.0M Venture - Series Unknown
Recursion Pharmaceuticals
October 2026

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Artificial Intelligence (AI) · Salt Lake City$200.0M Post-IPO Equity
BigHat Biosciences
September 2026

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

Artificial Intelligence (AI) · San Mateo$75.0M Series C
Basecamp Research
September 2026

Basecamp Research is a biotechnology company that uses artificial intelligence and biological data to develop therapeutics.

Artificial Intelligence (AI) · London$140.0M Series C
Enveda
September 2026

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

Artificial Intelligence (AI) · Boulder$311.0M Series E
Avava
September 2026

Avava is an aesthetic device company that uses laser and energy-based technologies to treat skin conditions.

Cosmetics · Waltham$30.0M Venture - Series Unknown
OpenEvidence
September 2026

OpenEvidence is a medical AI company that builds a search engine to support clinicians in making evidence-based decisions.

Analytics · Cambridge$250.0M Series E
Evvy
September 2026

Evvy is an AI precision medicine platform for women.

Artificial Intelligence (AI) · New York$40.0M Series B
Iambic
September 2026

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI) · San Diego$66.0M Debt Financing
Georgiamune
August 2026

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Biotechnology · Gaithersburg$92.7M Series B
Ratio Therapeutics
July 2026

Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Biopharma · Boston$70.0M Series C
Claris Biotherapeutics
July 2026

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

Biopharma · Jersey City$118.0M Series B
Cambrian Biopharma
July 2026

Cambrian is a distributed development company building therapeutics to lengthen health span.

Biopharma · New York$123.8M Venture - Series Unknown
AdvanCell
July 2026

AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.

Biotechnology · Sydney$315.0M Series D
Leo Cancer Care
July 2026

Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.

Health Care · Harley$65.0M Series D
Parabilis Medicines
June 2026

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Biopharma · Cambridge$75.0M Post-IPO Equity
Flourish
June 2026

Flourish Labs combines humans, AI & tech to provide employee coaching and AI-powered peer mental health support.

Artificial Intelligence (AI) · New York$500.0M Series A
9amHealth
May 2026

9amHealth offers a simplified approach to whole body health, focusing on weight loss, diabetes management, and heart health.

Health Care · Encinitas$26.0M Series B
ArriVent
May 2026

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Biotechnology · Pennsylvania Furnace$250.0M Post-IPO Equity
Thea
May 2026

Thea is an AI-powered skincare and dermatology app that gives personalized skincare advice, product recommendations.

Artificial Intelligence (AI) · New York$4.0M Pre-Seed
Odyssey Therapeutics
May 2026

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Biotechnology · Boston$25.0M Post-IPO Equity
Cartography Biosciences
May 2026

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

Biopharma · South San FranciscoVenture - Series Unknown

Where Catalio Capital Management invests

Health Care15
Biotechnology14
Therapeutics10
Artificial Intelligence (AI)9
Pharmaceutical8
Life Science7

About Catalio Capital Management's portfolio

How many companies has Catalio Capital Management invested in?▸

Catalio Capital Management has invested in 139 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Catalio Capital Management invest in?▸

Catalio Capital Management's top investment sectors include Health Care, Biotechnology, Therapeutics, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 29 different industry categories.

What is Catalio Capital Management's largest investment?▸

Among tracked funding rounds, Flourish received $500.0M in a Series A round. Catalio Capital Management's total known invested capital is $11.4B.

What is the average investment size for Catalio Capital Management?▸

Catalio Capital Management's average investment size is $82.0M across its portfolio of 139 companies.

What are Catalio Capital Management's most recent investments?▸

Recent Catalio Capital Management portfolio additions include Somethings, XRHealth, Star Therapeutics, Recursion Pharmaceuticals, BigHat Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 139 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →